Clinical trial
PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2
NCT03271281 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 4, 2017
- Completion date
- December 31, 2021
- Enrollment
- 113 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.